Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Boucher

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Health Management Technology|August 29, 2007
"To reach a representative, please click the icon". A Blue's call center Web-based VoIP solution empowers providers and saves timeDavid Boucher
The Journal of Physical Chemistry. B|October 18, 2016
Solubility Characteristics of PCBM and C<sub>60</sub>David Boucher, Jason Howell
The Journal of Physical Chemistry. B|April 11, 2017
A Functional Approach to Solubility Parameter ComputationsJason Howell, Miranda Roesing, David Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2022
Pre- and Postlicensure Animal Efficacy Studies Comparing Anthrax AntitoxinsRaymond M Slay, Rachel Cook, Katherine Hendricks, et al.
Experimental Brain Research|April 2, 2024
The impact of weight and negative body image on the body schema in undergraduate womenJean-David Boucher, Jessica Bourgin, Johana Lassiaz, et al.
FEMS Microbiology Letters|June 30, 2010
Characterization of a lipopolysaccharide mutant of Leptospira derived by growth in the presence of an anti-lipopolysaccharide monoclonal antibodySonia Zapata, Gabriel Trueba, Dieter M Bulach, et al.
JAMA Oncology|July 9, 2016
Prospective Study of Repeated Biopsy Feasibility and Acquired Resistance at Disease Progression in Patients With Advanced EGFR Mutant Lung Cancer Treated With Erlotinib in a Phase 2 TrialAmanda J Redig, Daniel B Costa, Myriam Taibi, et al.
Frontiers in Neurorobotics|May 8, 2012
I Reach Faster When I See You Look: Gaze Effects in Human-Human and Human-Robot Face-to-Face CooperationJean-David Boucher, Ugo Pattacini, Amelie Lelong, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|March 11, 2008
Medical tourismRonald C Merrell, David Boucher, Laura Carabello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2016
A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II TrialMasahiko Yanagita, Amanda J Redig, Cloud P Paweletz, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Health Management Technology|August 29, 2007
"To reach a representative, please click the icon". A Blue's call center Web-based VoIP solution empowers providers and saves timeDavid Boucher
The Journal of Physical Chemistry. B|October 18, 2016
Solubility Characteristics of PCBM and C<sub>60</sub>David Boucher, Jason Howell
The Journal of Physical Chemistry. B|April 11, 2017
A Functional Approach to Solubility Parameter ComputationsJason Howell, Miranda Roesing, David Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2022
Pre- and Postlicensure Animal Efficacy Studies Comparing Anthrax AntitoxinsRaymond M Slay, Rachel Cook, Katherine Hendricks, et al.
Experimental Brain Research|April 2, 2024
The impact of weight and negative body image on the body schema in undergraduate womenJean-David Boucher, Jessica Bourgin, Johana Lassiaz, et al.
FEMS Microbiology Letters|June 30, 2010
Characterization of a lipopolysaccharide mutant of Leptospira derived by growth in the presence of an anti-lipopolysaccharide monoclonal antibodySonia Zapata, Gabriel Trueba, Dieter M Bulach, et al.
JAMA Oncology|July 9, 2016
Prospective Study of Repeated Biopsy Feasibility and Acquired Resistance at Disease Progression in Patients With Advanced EGFR Mutant Lung Cancer Treated With Erlotinib in a Phase 2 TrialAmanda J Redig, Daniel B Costa, Myriam Taibi, et al.
Frontiers in Neurorobotics|May 8, 2012
I Reach Faster When I See You Look: Gaze Effects in Human-Human and Human-Robot Face-to-Face CooperationJean-David Boucher, Ugo Pattacini, Amelie Lelong, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|March 11, 2008
Medical tourismRonald C Merrell, David Boucher, Laura Carabello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2016
A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II TrialMasahiko Yanagita, Amanda J Redig, Cloud P Paweletz, et al.
Pageof 2